Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity

Major obstacles in immunotherapies include toxicities associated with systemic administration of therapeutic agents, as well as low tumor lymphocyte infiltration that hampers the efficacies. In this study, we report a mesenchymal stem cell (MSC)-based immunotherapeutic strategy in which MSCs specifi...

Full description

Saved in:
Bibliographic Details
Published in:Mol Ther
Main Authors: Yin, Pan, Gui, Liming, Wang, Caihong, Yan, Jingjing, Liu, Min, Ji, Lu, Wang, You, Ma, Bin, Gao, Wei-Qiang
Format: Artigo
Language:Inglês
Published: American Society of Gene & Cell Therapy 2020
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704751/
https://ncbi.nlm.nih.gov/pubmed/32827461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.08.005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items